Bryan Johnson's Protocol
primary document · 2026
LINK
SUMMARY
Blueprint's own current (23 January 2026) description of Johnson's protocol, the practitioner's/company's own material. Reports self-measured biomarker figures as of that update: an epigenetic 'speed of aging' score of 0.48, telomere length reported as age-equivalent to a 10-to-15-year-old, and a claimed skin-age reduction from 64 to 36. Frames sleep as the protocol's foundation ('the world's #1 longevity drug' in the company's own words) and names Blueprint 'the world's first Don't Die protocol.' All figures are self-reported and uncontrolled; none is benchmarked against an independent cohort or a hard endpoint.
NOTES
Blueprint’s own 2026 update is used in the case for the most current self-reported biomarker figures, cited paraphrased rather than quoted verbatim (the fetched extraction could not be confirmed word-for-word against the live page with full confidence). It is treated as the subject’s own material under the sourced-critique standard and is read alongside, not instead of, the independent critique sources in this bundle.